All Stories

  1. Does the evidence support circumcision of infant males in the United Kingdom?—a systematic review
  2. FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-aged Men: Kuakini Honolulu Heart Program
  3. An error-prone study of penile problems
  4. Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’
  5. Circumcision policy by Australian physicians' organisation is a threat to community health
  6. Novel protective effect of the FOXO3 longevity genotype on mechanisms of cellular aging in Okinawans
  7. Neonatal Male Circumcision: Clearly Beneficial for Public Health or an Ethical Dilemma? A Systematic Review
  8. Comment on “Comparison the Diameter of the Urethral Meatus Before and After Circumcision and Evaluation of Urethral Stenosis”
  9. Flaws in arguments by opponents of childhood male circumcision
  10. FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk
  11. Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype
  12. Genes That Extend Lifespan May Do So by Mitigating the Increased Risk of Death Posed by Having Hypertension
  13. Vascular endothelial growth factor receptor 1 gene (FLT1) longevity variant increases lifespan by reducing mortality risk posed by hypertension
  14. Letter to Editor regarding: Referrals from primary care with foreskin symptoms: Is there really room for improvement?
  15. Proteomic basis of mortality resilience mediated by FOXO3 longevity genotype
  16. Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally
  17. Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage
  18. FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan
  19. Re: The medical evidence on non-therapeutic circumcision of infants and boys—setting the record straight
  20. Critical evaluation of contrasting evidence on whether male circumcision has adverse psychological effects: A systematic review
  21. Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity
  22. Circumcision and Risk of HIV among Males from Ontario, Canada. Letter.
  23. Evidence-based circumcision policy for Australia
  24. Re: Sensory innervation of the human male prepuce—Meissner’s corpuscles predominate
  25. Causes and consequences of the decline in circumcision in Australia
  26. Association with Longevity of Phosphatidylinositol 3-Kinase Regulatory Subunit 1 Gene Variants Stems from Protection against Mortality Risk in Men with Cardiovascular Disease
  27. Association of growth hormone receptor gene variant with longevity in men is due to amelioration of increased mortality risk from hypertension
  28. Lifespan extension conferred by mitogen-activated protein kinase kinase kinase 5 (MAP3K5) longevity-associated gene variation is confined to at-risk men with a cardiometabolic disease
  29. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease
  30. Voluntary Medical Male Circumcision Proves Robust for Mitigating Heterosexual Human Immunodeficiency Virus Infection
  31. The Contrasting Evidence Concerning the Effect of Male Circumcision on Sexual Function, Sensation, and Pleasure: A Systematic Review
  32. Prevalence of Phimosis in Males of All Ages: Systematic Review
  33. The advent of human papillomavirus detection for cervical screening
  34. In silico analysis of human renin gene–gene interactions and neighborhood topologically associated domains suggests breakdown of insulators contribute to ageing-associated diseases
  35. Critical evaluation of arguments opposing male circumcision: A systematic review
  36. Genetic and epigenetic regulation of human aging and longevity
  37. Sex and Male Circumcision: Women’s Preferences Across Different Cultures and Countries: A Systematic Review
  38. The role of oxygen in regulating microRNAs in control of the placental renin–angiotensin system
  39. Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
  40. Letter by Morris Regarding Article, “Genetics of Human Longevity Within an Eco-Evolutionary Nature-Nurture Framework”
  41. Meatal stenosis: getting the diagnosis right
  42. Letter to the Editor
  43. Reply by the Authors
  44. Regulation of the human placental (pro)renin receptor-prorenin-angiotensin system by microRNAs
  45. Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele
  46. Re: Cultural background, non-therapeutic circumcision and the risk of meatal stenosis and other urethral stricture disease: Two nationwide register-based cohort studies in Denmark 1977–2013
  47. Transcriptomics in Twins Separates Genetic From Environmental Effects on Gene Expression and Blood Pressure
  48. FOXO3 and Exceptional Longevity: Insights From Hydra to Humans
  49. Analysis of Polymorphisms in 59 Potential Candidate Genes for Association With Human Longevity
  50. FOXO3 cell resilience gene neighborhood
  51. Does Circumcision Increase Meatal Stenosis Risk?—A Systematic Review and Meta-analysis
  52. Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women
  53. Blood Pressure Genome-Wide Association Studies, Missing Heritability, and Omnigenics
  54. Longevity "gene factory"
  55. Gene Team in Blood Pressure Genetics
  56. CDC's Male Circumcision Recommendations Represent a Key Public Health Measure
  57. Infant circumcision: Evidence, policy, and practice
  58. Penile inflammatory skin disorders and the preventive role of circumcision
  59. Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy
  60. Expertise and Ideology in Statistical Evaluation of Circumcision for Protection against HIV Infection
  61. Re: Examining Penile Sensitivity in Neonatally Circumcised and Intact Men Using Quantitative Sensory Testing
  62. Longevity-AssociatedFOXO3Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations
  63. Association of Polymorphisms in Connective Tissue Growth Factor and Epidermal Growth Factor Receptor Genes With Human Longevity
  64. The FoxO3 gene and cause‐specific mortality
  65. Circumcision is a primary preventive against HIV infection: Critique of a contrary meta-regression analysis by Van Howe
  66. Erratum to: Estimation of country-specific and global prevalence of male circumcision
  67. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer
  68. Estimation of country-specific and global prevalence of male circumcision
  69. Countries with high circumcision prevalence have lower prostate cancer mortality
  70. Critical evaluation of unscientific arguments disparaging affirmative infant male circumcision policy
  71. Reply to Letter by Dr. Christoph Kupferschmid: Commentary on "Countries with high circumcision prevalence have lower prostate cancer mortality"
  72. Effect of oxygen on the expression of renin–angiotensin system components in a human trophoblast cell line
  73. Implications of circumcision complications for hospital policy
  74. Male circumcision to prevent syphilis in 1855 and HIV in 1986 is supported by the accumulated scientific evidence to 2015: Response to Darby
  75. Association Analysis ofFOXO3Longevity Variants With Blood Pressure and Essential Hypertension
  76. Commentary: Do the Benefits of Male Circumcision Outweigh the Risks? A Critique of the Proposed CDC Guidelines
  77. Brain-stem microRNAs implicated in hypertension
  78. In developed countries male circumcision prevalence is inversely related to HIV prevalence
  79. Blood Pressure Genetics Just Don’t Add Up
  80. ‘Circumcision pain’ unlikely to cause autism
  81. Effect of male circumcision on sexual function
  82. The literature supports policies promoting neonatal male circumcision in north america.
  83. Debating male circumcision for HIV prevention: A one-sided argument does not represent a legitimate ‘controversy’ analysis – Reply to de Camargo et al.
  84. Male circumcision for protection against HIV infection in sub-Saharan Africa: The evidence in favour justifies the implementation now in progress
  85. Renin, Genes, MicroRNAs, and Renal Mechanisms Involved in Hypertension
  86. <b><i>FOXO3:</i></b> A Major Gene for Human Longevity - A Mini-Review
  87. Signatures of miR-181a on the Renal Transcriptome and Blood Pressure
  88. Scientific evidence dispels false claims about circumcision
  89. In reply—Bias and Male Circumcision
  90. Genetic Variation in the Raptor Gene Is Associated With Overweight But Not Hypertension in American Men of Japanese Ancestry
  91. Shorter Men Live Longer: Association of Height with Longevity and FOXO3 Genotype in American Men of Japanese Ancestry
  92. Circumcision Rates in the United States: Rising or Falling? What Effect Might the New Affirmative Pediatric Policy Statement Have?
  93. Analysis of genes in a key pathway to see if any are involved in the genetic basis of longevity
  94. Circumcision Is a Religious/Cultural Procedure, Not a Medical Procedure—Reply
  95. Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny
  96. Circumcision does not alter sexual function, sensitivity or pleasure for men
  97. Legal Threat to Infant Male Circumcision
  98. A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice
  99. Recommendation by a law body to ban infant male circumcision has serious worldwide implications for pediatric practice and human rights
  100. Veracity and rhetoric in paediatric medicine: a critique of Svoboda and Van Howe's response to the AAP policy on infant male circumcision
  101. Association Analyses of Insulin Signaling Pathway Gene Polymorphisms With Healthy Aging and Longevity in Americans of Japanese Ancestry
  102. Circumcision and Lifetime Risk of Urinary Tract Infection: A Systematic Review and Meta-Analysis
  103. ZRANB2 localizes to supraspliceosomes and influences the alternative splicing of multiple genes in the transcriptome
  104. Male circumcision decreases penile sensitivity as measured in a large cohort
  105. Seven sirtuins for seven deadly diseases ofaging
  106. Legal arguments opposing infant male circumcision are flawed
  107. Should Male Circumcision be Advocated for Genital Cancer Prevention?
  108. BOYLE AND HILL'S CIRCUMCISION ‘PHALLUSIES’
  109. The 2010 Royal Australasian College of Physicians' policy statement ‘Circumcision of infant males’ is not evidence based
  110. Circumcision reduces prostate cancer risk
  111. Neurogenic Hypertension: Revelations from Genome-Wide Gene Expression Profiling
  112. Review: A critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries
  113. Biological basis for the protective effect conferred by male circumcision against HIV infection
  114. A 'snip' in time: what is the best age to circumcise?
  115. Letter by Marques and Morris Regarding Article, “Signature MicroRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection”
  116. Benefits of Male Circumcision
  117. Current Medical Evidence Supports Male Circumcision
  118. Infant male circumcision: An evidence-based policy statement
  119. Fetal Sex Affects Expression of Renin-Angiotensin System Components in Term Human Decidua
  120. Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAs
  121. Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs
  122. A “SNP in Time” for SCNN1G to Join the “Highly Likely” List of Genes for Essential Hypertension
  123. Does sexual function survey in Denmark offer any support for male circumcision having an adverse effect?
  124. Male Circumcision: An Appraisal of Current Instrumentation
  125. Exposé of fallacious claims that male circumcision will increase HIV infections in Africa
  126. ‘How to contain generalized HIV epidemics’ article misconstrues the evidence
  127. Genes Influencing Circadian Differences in Blood Pressure in Hypertensive Mice
  128. Circumcision Denialism Unfounded and Unscientific
  129. Renin, Genes, and Beyond
  130. Molecular characterization of renin-angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section
  131. Renin
  132. Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa
  133. The Strong Protective Effect of Circumcision against Cancer of the Penis
  134. Circumcision survey misleading
  135. Commentary on Resveratrol and Hormesis: Resveratrol—a hormetic marvel in waiting?
  136. The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV
  137. Meta-Analysis of Genome-Wide Gene Expression Differences in Onset and Maintenance Phases of Genetic Hypertension
  138. Keratinization of the adult male foreskin and implications for male circumcision
  139. Sympathetic Meta-Analysis of Adrenoceptor Gene Variants in Hypertension
  140. The molecular basis of longevity, and clinical implications
  141. Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits
  142. Hormesis as a Pro-Healthy Aging Intervention in Human Beings?
  143. MEDICAID COVERAGE OF NEWBORN CIRCUMCISION: A HEALTH PARITY RIGHT OF THE POOR
  144. Might a Leptin Gene Variant Affect Blood Pressure in Obese Brazilians?
  145. The zinc fingers of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that recognize 5′ splice site-like sequences
  146. Xylosyltransferase Gene Variants and Their Role in Essential Hypertension
  147. RBM4: A multifunctional RNA-binding protein
  148. Errors in meta-analysis by Van Howe
  149. GRK4 Genetics and Response to  -Blocker
  150. FLUORESCENCE ACTIVATED CELL SORTING OF TRANSIENTLY TRANSFECTED As4.1 CELLS SHOWS RENIN ENHANCER DIRECTS ON/OFF SWITCHING OF RENIN PROMOTER IN VITRO
  151. Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?
  152. ZRANB2: Structural and functional insights into a novel splicing protein
  153. Re: ‘RS Van Howe, FM Hodges. The carcinogenicity of smegma: debunking a myth.’ An example of myth and mythchief making?
  154. Renin Enhancer Is Crucial for Full Response in Renin Expression to an In Vivo Stimulus
  155. Why circumcision is a biomedical imperative for the 21stcentury
  156. The Effect of Resveratrol on a Cell Model of Human Aging
  157. Reduced Cardiovascular Reactivity to Stress but Not Feeding in Renin Enhancer Knockout Mice
  158. FINE‐TOUCH PRESSURE THRESHOLDS IN THE ADULT PENIS
  159. CASE NUMBER AND THE FINANCIAL IMPACT OF CIRCUMCISION IN REDUCING PROSTATE CANCER
  160. The Human Pseudoautosomal Region (PAR): Origin, Function and Future
  161. Identification of a Novel Polymorphism in the 3′UTR of the l -Arginine Transporter Gene SLC7A1
  162. Climate not cultivars in the NO-ing of red wines
  163. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  164. Circumcision in Australia: prevalence and effects on sexual health
  165. Re: Cost Analysis of Neonatal Circumcision in a Large Health Maintenance Organization
  166. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo
  167. XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265
  168. Renin Enhancer Is Critical for Control of Renin Gene Expression and Cardiovascular Function
  169. Lark Is the Splicing Factor RBM4 and Exhibits Unique Subnuclear Localization Properties
  170. RACP's policy statement on infant male circumcision is ill-conceived
  171. Dietary approaches that delay age-related diseases
  172. Dissecting Hypertension by Obesity Identifies a Locus at 1p36
  173. No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36
  174. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer
  175. Genome-Wide Scan for Hypertension in Sydney Sibships: The GENIHUSS Study
  176. Angiotensin receptor gene variant goes with the flow
  177. BRCTx Is a Novel, Highly Conserved RAD18-Interacting Protein
  178. Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region
  179. Critique of ?sibpair studies implicate chromosome 18 in essential hypertension? by S. Rutherford, M.P. Johnson, and L.R. Griffiths. 2004. Am J Med Genet 126A:241-247
  180. The scorching breath of angiotensin
  181. cAMP controls human renin mRNA stability via specific RNA‐binding proteins
  182. No association of Angiotensin-Converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension*1
  183. Circumcision rate too low?
  184. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension
  185. Chromatic and spatial properties of parvocellular cells in the lateral geniculate nucleus of the marmoset (Callithrix jacchus)
  186. WNK4 Intron 10 Polymorphism Is Not Associated With Hypertension
  187. HADHB, HuR, and CP1 Bind to the Distal 3′-Untranslated Region of Human Renin mRNA and Differentially Modulate Renin Expression
  188. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension
  189. Tumor necrosis factor receptor 2 mRNA in rat models of hypertension
  190. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension
  191. Association of Obesity, but not Diabetes or Hypertension, with Glucocorticoid Receptor N363S Variant
  192. The Structure of the Zinc Finger Domain from Human Splicing Factor ZNF265 Fold
  193. Renin: from ‘pro’ to promoter
  194. Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant
  195. Essential Hypertension: Genes and Dreams
  196. Overweight, But Not Hypertension, Is Associated with SAH Polymorphisms in Caucasians with Essential Hypertension
  197. Lipopolysaccharide Reverses Adrenocorticotrophic Hormone-Induced Hypertension in the Rat
  198. A Distinct Subclass of Mammalian Striated Myosins: Structure and Molecular Evolution of "Superfast" or Masticatory Myosin Heavy Chain
  199. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes
  200. Association analysis of polymorphisms at the interleukin‐1 locus in essential hypertension
  201. Critique of “Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension” by Rutherford et al., Human Genetics, published online September 2001
  202. RENIN GENE EXPRESSION: THE SWITCH AND THE FINGERS
  203. Association of β2-adrenoceptor Gln27Glu variant with body weight but not hypertension
  204. ZNF265—a novel spliceosomal protein able to induce alternative splicing
  205. G-protein β3 subunit gene splice variant in obesity and overweight
  206. TNFRSF1Bin Genetic Predisposition to Clinical Neuropathy and Effect on HDL Cholesterol and Glycosylated Hemoglobin in Type 2 Diabetes
  207. Decreased Renal Expression of Nitric Oxide Synthase Isoforms in Adrenocorticotropin-Induced and Corticosterone-Induced Hypertension
  208. Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease
  209. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension
  210. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor
  211. Chromosome localization and characterization of the mouse and human zinc finger protein 265 gene
  212. Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
  213. High penetrance, overweight, and glucocorticoid receptor variant: case-control study
  214. Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity
  215. The Gly460Trp variant of α-adducin is not associated with hypertension in white anglo-Australians
  216. Different Frequencies of Inducible Nitric Oxide Synthase Genotypes in Older Hypertensives
  217. G-Protein β3 Subunit Gene ( GNB3 ) Variant in Causation of Essential Hypertension
  218. SCANNING THE GENOME FOR ESSENTIAL HYPERTENSION LOCI
  219. A LINKAGE AND CROSS‐SECTIONAL STUDY OF HYPERTENSION AND OBESITY USING A POLY(A) Alu‐REPEAT POLYMORPHISM AT THE GLUCAGON RECEPTOR GENE LOCUS (17q25)
  220. Insulin receptor exon 11+/− isoform mRNA in spontaneously hypertensive and adrenocorticotropin-hypertensive rats
  221. Association of a low density lipoprotein receptor microsatellite variant with obesity
  222. Association Analyses of SA Gene Variant in Essential Hypertensives
  223. Insulin Receptor Gene in Hypertension
  224. Transactivation of the Human Renin Promoter by the Cyclic AMP/Protein Kinase A Pathway Is Mediated by Both cAMP-responsive Element Binding Protein-1 (CREB)-dependent and CREB-independent Mechanisms in Calu-6 Cells
  225. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension
  226. HYPOTHESIS: GLUCAGON RECEPTOR GLYCINE TO SERINE MISSENSE MUTATION CONTRIBUTES TO ONE IN 20 CASES OF ESSENTIAL HYPERTENSION*
  227. Effect of angiotensin-converting enzyme genotype on renin-angiotensin components in hypertensives
  228. Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells
  229. NO DIFFERENCE IN THE PROPORTION OF INSULIN RECEPTOR EXON 11 +/‐ ISOFORM mRNA IN THE LIVER OF RATS AFTER DEVELOPMENT OF HYPERTENSION
  230. EXAMINATION OF THE ROLE OF NITRIC OXIDE SYNTHASE AND RENAL KALLIKREIN AS CANDIDATE GENES FOR ESSENTIAL HYPERTENSION
  231. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives
  232. Glucagon receptor gene mutation in essential hypertension
  233. SOME PHYSIOLOGICAL OUTCOMES OF RENIN GENE STUDIES
  234. Renin mRNA, Quantified by Polymerase Chain Reaction, in Renal Hypertensive Rat Tissues
  235. CROSS‐SECTIONAL STUDY OF A MICROSATELLITE MARKER IN THE LOW DENSITY LIPOPROTEIN RECEPTOR GENE IN OBESE NORMOTENSIVES
  236. RENIN mRNA CONCENTRATION IN RAT HYPOTHALAMUS IS DECREASED BY ENALAPRIL
  237. Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives
  238. Fourier Transform Infrared Spectroscopy of Dysplastic, Papillomavirus-Positive Cervicovaginal Lavage Specimens
  239. Human renin 5′-flanking DMA to nucleotide -2750
  240. Function of human renin proximal promoter DNA
  241. FREQUENCIES OF VARIANTS OF CANDIDATE GENES IN DIFFERENT AGE GROUPS OF HYPERTENSIVES
  242. SIMILARITY OF BLOOD PRESSURE FOR EACH GENOTYPE OF THE INSERTION/DELETION POLYMORPHISM OF THE DIPEPTIDYL CARBOXYPEPTIDASE‐1 GENE IN DIFFERENT AGE GROUPS OF PATIENTS WITH SEVERE, FAMILIAL ESSENTIAL HYPERTENSION
  243. Proximal 2.6 kb of 5′-flanking DNA is insufficient for human renin promoter activity in renin-synthesizing chorio-decidual cells
  244. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals.
  245. NO EFFECT OF KININS ON DNA SYNTHESIS IN LNCaP PROSTATE CANCER CELLS
  246. No difference in substrate affinity of plasma dipeptidyl carboxypeptidase-1 encoded by the I and D allelic forms of its gene
  247. Isolation and Structure of Cat Superfast Myosin Light Chain-2 cDNA and Evidence for the Identity of Its Human Homologue
  248. Significant Relationships of Plasma Lipids and Body Mass Index with Polymorphisms at the Linked Low-Density-Lipoprotein Receptor Gene and Insulin Receptor Gene Loci (19P13.2) in Essential Hypertensive Patients
  249. Identification of Cyclic AMP Response Element in the Human Renin Gene
  250. GENOTYPIC INFLUENCE ON PLASMA DIPEPTIDYL CARBOXYPEPTIDASE‐1 ACTIVITY IN HYPERTENSIVES
  251. Cross-Sectional Analysis of Met235→Thr Variant of Angiotensinogen Gene in Severe, Familial Hypertension
  252. Neuropeptide-Y Y1 Receptor Gene Polymorphism: Cross-Sectional Analyses in Essential Hypertension and Obesity
  253. Simple microwave and thermal cycler boiling methods for preparation of cervicovaginal lavage cell samples prior to PCR for human papillomavirus detection
  254. Independent, Marked Associations of Alleles of the Insulin Receptor and Dipeptidyl Carboxypeptidase-1 Genes with Essential Hypertension
  255. CHROMOSOME 17q23: A LOCUS FOR CARDIOVASCULAR DISEASE
  256. SPECIES DIFFERENCES IN BINDING OF SUBMANDIBULAR NUCLEAR PROTEINS TO RENIN PROMOTER DNA
  257. Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atrium
  258. Identification of essential hypertension genes
  259. Reassignment of Human Renin Gene to Chromosome 1q32 in Studies of a (1;4)(q42;p16) Translocation
  260. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives
  261. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension
  262. Molecular biology of renin II: Gene control by messenger RNA, transfection and transgenic studies
  263. Molecular biology of renin I: Gene and protein structure, synthesis and processing
  264. Papillomavirus DNA and colposcopy instruments
  265. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension
  266. Transient expression analyses of DNA extending 2.4 kb upstream of the human renin gene
  267. Prorenin and gene activation
  268. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension
  269. RENIN GENE EXPRESSION IN VARIOUS TISSUES DETERMINED BY SINGLE‐STEP POLYMERASE CHAIN REACTION
  270. A LOCUS ON THE LONG ARM OF CHROMOSOME 1 AS A POSSIBLE CAUSE OF ESSENTIAL HYPERTENSION
  271. Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men.
  272. Molecular genetics links renin to hypertension
  273. Localization of Human Glandular Kallikrein-1 Gene to Chromosome 19ql3.3–13.4 by in situ Hybridization
  274. Automated polymerase chain reaction for papillomavirus screening of cervicovaginal lavages: Comparison with dot‐blot hybridization in a sexually transmitted diseases clinic population
  275. Localization of human cardiac β-myosin heavy chain gene (MYH7) to chromosome 14q12 by in situ hybridization
  276. Human renin protein and gene structures: present and future targets for renin blockade in treatment of hypertension
  277. hGK‐1: A KALLIKREIN GENE EXPRESSED IN HUMAN PROSTATE
  278. Polymerase chain reaction for fast, nonradioactive detection of high‐ and low‐risk papillomavirus types in routine cervical specimens and in biopsies
  279. The B Subunit of Coagulation Factor XIII Is Linked to Renin and the Duffy Blood Group to α-Spectrin on Human Chromosome 1
  280. PAPILLOMAVIRUS SCREENING OF CERVICAL LAVAGES BY POLYMERASE CHAIN REACTION
  281. Triton WR-1339 injected into rats enters renal renin granules
  282. Human Papillomavirus: The Untreated Male Reservoir
  283. THREE Alu REPEATED SEQUENCES ASSOCIATED WITH A HUMAN GLANDULAR KALLIKREIN GENE
  284. Frequency in hypertensives of alleles for a RFLP associated with the renin gene
  285. Human Renin Gene: Extended Sequence of 5'-Flanking DNA and its Linkage to CAT Gene for Studies of Regulation
  286. Molecular Weights of Renin and Inactive Renin in Mouse Plasma
  287. Primary Structure of a Human Glandular Kallikrein Gene
  288. Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization
  289. RENIN SECRETION FROM MALIGNANT PULMONARY METASTATIC TUMOUR CELLS OF VASCULAR ORIGIN
  290. Cell biology of cultured anogenital warts
  291. Regional chromosomal assignment of human renin gene to 1q12→qter and use in linkage studies in Charcot-Marie-Tooth disease
  292. ACTIVATION BY PUFF ADDER VENOM OF INACTIVE RENIN IN NORMAL AND HYPERTENSIVE RAT PLASMA
  293. Human cardiac myosin heavy chain genes. Isolation of a genomic DNA clone and its characterization and of a second unique clone also present in the human genome.
  294. New possibilities for intracellular renin and inactive renin now that the structure of the human renin gene has been elucidated
  295. Stimulation by thyroid hormone of renin mRNA in mouse submandibular gland
  296. EVOLUTION OF RENIN
  297. Antihypertensive Effect of Sialoadenectomy in One-Kidney, One Clip Hypertension in the Rat
  298. Studies of the Regulation of Mouse Renin Genes by Measurement of Renin Messenger Ribonucleic Acid*
  299. A STRUCTURAL ANALYSIS OF HUMAN RENIN
  300. ISOLATION OF GENOMIC CLONES CODING FOR THE HEAVY CHAINS OF TWO HUMAN CARDIAC MYOSINS
  301. Primary Structure of the Human Renin Gene
  302. STRUCTURE OF HUMAN RENIN AND EXPRESSION OF THE RENIN GENE
  303. DETECTION OF RENIN mRNA IN MOUSE KIDNEY AND SUBMANDIBULAR GLAND BY HYBRIDIZATION WITH RENIN cDNA*
  304. Immunohistochemistry of tonin in rat submandibular gland during development, lactation and secretion
  305. SYNTHESIS OF MOUSE RENIN AS A 2‐5‐33‐5 KILODALTON PRE‐PRO‐ TWO‐CHAIN MOLECULE AND USE OF ITS cDNA TO IDENTIFY THE HUMAN GENE
  306. PLASMA VASOPRESSIN IN HYPERCALCAEMIC STATES
  307. Clearance and Metabolism of125I-Labeled Tonin in the Rat*
  308. A simple method of isolating tonin using chromatofocusing
  309. The Effect of Bromocriptine on Circulating Vasopressin
  310. Investigation of the presence of "renopressin" in kidney extracts from rabbits and rats.
  311. Biosynthesis of Preprorenin. Studies Using Whole Tissue, A Cell-Free System, andE. ColiContaining cDna Inserted at thePstI Site of Plasmid pBR322
  312. Kallikrein and Renin: Molecular Biology and Biosynthesis
  313. BIOSYNTHESIS OF PREPRORENIN AND INTRACELLULAR CONVERSION OF PRORENIN TO RENIN
  314. Evidence that the arginine esteropeptidase (gamma) subunit of nerve growth factor can activate inactive renin
  315. Mechanism of activation of inactive renin in human plasma by puff adder venom
  316. Renin in mouse but not in rat submandibular glands
  317. ACTIVATION OF PLASMA PREKALLIKREIN AND INACTIVE RENIN BY PUFF ADDER VENOM
  318. Activation of inactive renin during the selective destruction of proteinase inhibitors in human plasma by a metalloproteinase in Bitis arietans venom
  319. Effect of angiotensin II and sodium depletion on angiotensinogen production
  320. Properties of inactive renin in human plasma
  321. Inhibitory by α-adrenoceptor agonists of renin release in vitro
  322. Localization of Angiotensinogen in Rat Liver by Immunocytochemistry*
  323. Partial purification of dog angiotensinogen.
  324. Properties of the activation by pepsin of inactive renin in human amniotic fluid
  325. A “Renin-Like” Enzymatic Action of Cathepsin D and the Similarity in Subcellular Distributions of “Renin-Like” Activity and Cathepsin D in the Midbrain of Dogs*
  326. The Distribution of Angiotensinogen in Dog Brain Studied by Cell Fractionation*
  327. The Renin-Angiotensin System
  328. Activation of Human Inactive (“Pro-”) Renin by Cathepsin D and Pepsin*
  329. Identification of “Angiotensin Immunoreactive Material” in Rat Kidney1
  330. Mechanism of interference by chelating agents and sucrose in radioimmunoassay of angiotensin I
  331. The renin-angiotensin-aldosterone system in rabbits with congestive heart failure produced by aortic constriction.
  332. Specific radioactivity of radioimmunoassay tracer determined by self-displacement: A re-evaluation
  333. Isolation of Renin Granules from Rat Kidney Cortex and Evidence for an Inactive Form of Renin (Prorenin) in Granules and Plasma
  334. Renin substrate in granules from rat kidney cortex
  335. RELEASE OF RENIN FROM GLOMERULI ISOLATED FROM RAT KIDNEY
  336. Renin Release from Isolated Rat Glomeruli
  337. Clearance from the circulation of the rat and whole‐body autoradiography in the mouse of 125I‐labelled neurophysins
  338. RELEASE AND CLEARANCE OF NEUROPHYSINS AND POSTERIOR PITUITARY HORMONES*
  339. CLEARANCE AND METABOLISM OF NEUROPHYSINS BY RAT KIDNEY
  340. The activation of renin in human amniotic fluid by proteolytic enzymes